CureVac N.V.
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. CureVac N.V.'s past years’ income statements indicate that its last revenue has decreased compared to the previous period by 20% to $53,758,000. Profit margin reached -484%. Total operating expenses were $203,599,000.

Profit Margin

CureVac N.V. (NASDAQ:CVAC): Profit margin
2018 12.87M -71.24M -553.5%
2019 17.41M -99.87M -573.46%
2020 48.9M -129.07M -263.96%
2021 102.99M -411.71M -399.76%
2022 67.42M -249.02M -369.37%
2023 53.75M -260.16M -483.96%

CVAC Income Statement (2018 – 2023)

2023 2022 2021 2020 2019 2018
Revenue
Revenue
53.75M67.42M102.99M48.9M17.41M12.87M
Cost of revenue
124.36M183.99M238.19M14.17M27.98M17.74M
Gross profit
-70.60M-116.57M-135.20M34.72M-10.56M-4.87M
Operating exp.
Research and development
115.72M62.55M815.90M113.80M43.24M41.72M
Selling and marketing
424K417K1.74M733K1.75M1.08M
Total operating expenses
203.59M134.27M277.05M158.7M88.93M67.95M
Operating income
-274.20M-249.45M-412.26M-124.00M-99.49M-72.82M
Other income (expenses), net
14.23M302K-235K-20.03M-627K1.69M
Income before tax
-259.96M-249.15M-412.49M-129.8M-100.12M-71.13M
Income tax expense
198K-126K-782K-726K-252K110K
Net income
-260.16M-249.02M-411.71M-129.07M-99.87M-71.24M
Earnings per share
Basic EPS
-1.18-1.32-2.21-0.98-0.53-0.4
Diluted EPS
-1.18-1.32-2.21-0.98-0.53-0.4
Data sourceData sourceData sourceData source